Analytical Data
-
基因名
CPVL
- Application
-
别名
Carboxypeptidase; Carboxypeptidase vitellogenic like; carboxypeptidase WUG; CP-Mac carboxypeptidase; cpvl; CPVL_HUMAN; HVLP; MGC10029; Probable serine carboxypeptidase CPVL
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9H3G5
-
表达区间
1-476aa
-
氨基酸序列
MVGAMWKVIVSLVLLMPGPCDGLFRSLYRSVSMPPKGDSGQPLFLTPYIEAGKIQKGRELSLVGPFPGLNMKSYAGFLTVNKTYNSNLFFWFFPAQIQPEDAPVVLWLQGGPGGSSMFGLFVEHGPYVVTSNMTLRDRDFPWTTTLSMLYIDNPVGTGFSFTDDTHGYAVNEDDVARDLYSALIQFFQIFPEYKNNDFYVTGESYAGKYVPAIAHLIHSLNPVREVKINLNGIAIGDGYSDPESIIGGYAEFLYQIGLLDEKQKKYFQKQCHECIEHIRKQNWFEAFEILDKLLDGDLTSDPSYFQNVTGCSNYYNFLRCTEPEDQLYYVKFLSLPEVRQAIHVGNQTFNDGTIVEKYLREDTVQSVKPWLTEIMNNYKVLIYNGQLDIIVAAALTERSLMGMDWKGSQEYKKAEKKVWKIFKSDSEVAGYIRQVGDFHQVIIRGGGHILPYDQPLRAFDMINRFIYGKGWDPYVG
-
分子量
77.88 KDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CPVL (Cardiovascular Protein with an Unknown Function) is a member of the carboxypeptidase family, which plays a crucial role in protein metabolism and regulation within various biological processes. Recent research has highlighted its significance in cardiovascular disease and inflammation, making CPVL a potential target for therapeutic interventions. Understanding the structure, function, and regulatory mechanisms of CPVL can provide insights into its role in pathophysiological conditions, including atherosclerosis and heart failure. Previous studies have indicated that CPVL may influence the processing of bioactive peptides and modulate immune responses, further emphasizing its relevance in health and disease. Moreover, advancements in recombinant protein technology have facilitated the production and characterization of CPVL, paving the way for detailed investigations into its enzymatic properties and interactions with other proteins. These endeavors aim to elucidate the functional implications of CPVL in cardiovascular homeostasis and its potential as a biomarker or therapeutic target. As research progresses, the comprehensive understanding of CPVL may contribute significantly to developing novel strategies for managing cardiovascular disorders, ultimately improving patient outcomes and enhancing the quality of care in cardiovascular medicine.
